» Articles » PMID: 33883962

Correlation of Serum Ferritin and Liver Iron Concentration with Transient Liver Elastography in Adult Thalassemia Intermedia Patients with Blood Transfusion

Overview
Journal J Blood Med
Publisher Dove Medical Press
Specialty Hematology
Date 2021 Apr 22
PMID 33883962
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Iron overload is a common feature of thalassemia intermedia due to regular blood transfusion and increased gastrointestinal iron absorption. Early detection and adequate iron chelator can decrease morbidity and mortality from iron overload. Liver iron concentration (LIC) by MRI T2* is the best non-invasive way to measure body iron stores. However, this method is expensive and not available nationwide in Indonesia. The aim of this study was to identify liver iron overload and correlation of transferrin saturation, serum ferritin, liver MRI T2* and LIC with transient liver elastography in adult thalassemia intermedia patients.

Methods: This is a cross-sectional study of 45 patients with thalassemia intermedia with blood transfusion and with and without iron chelator therapy. The study was conducted at Cipto Mangunkusumo Hospital from August through October 2016. We performed measurements of transferrin saturation, serum ferritin level, transient liver elastography and liver MRI T2*. Pearson and Spearman correlation tests were used to evaluate the correlation between transient liver elastography with transferrin saturation, serum ferritin, liver MRI T2*and LIC.

Results And Discussion: This study showed that 64.4% of study subjects are β-Hb E thalassemia intermedia. Furthermore, 84.4% of study subjects have regular transfusion. Based on liver MRI T2*all subjects suffered from liver iron overload, 48.9% had severe degree. Median value of liver MRI T2* was 1.6 ms. Mean serum ferritin was 2831 ng/mL, with median transferrin saturation of 66%. Mean of LIC corresponding to liver MRI T2* and mean liver stiffness measurement was 15.36±7.37 mg Fe/gr dry weight and 7.7±3.8 kPa, respectively. Liver stiffness correlated with serum ferritin (=0.651; p=0.000), liver MRI T2* (=-0.357; p=0.016), and LIC (=0.433; p=0.003). No correlation was found between liver elastography and transferrin saturation (=0.204; p=0.178).

Conclusion: Serum ferritin, liver MRI T2*and LIC correlated with liver elastography. No correlation was found between transferrin saturation and liver elastography.

Citing Articles

Correlation of Transient Elastography with Liver Iron Concentration and Serum Ferritin Levels in Patients with Transfusion-Dependent Thalassemia Major from Oman.

Khan H, Panjwani V, Al Rahbi S, Eltigani A, Qureshi R, Unissa K Mediterr J Hematol Infect Dis. 2023; 15(1):e2023048.

PMID: 37705529 PMC: 10497312. DOI: 10.4084/MJHID.2023.048.


Correlation Between Serum Ferritin and Degree of Hepatic Fibrosis on Fibroscan in Thalassemic Patients.

Ali M, Borhany M, Butt A, Munawar Ali R, Kashif S, Wahaj M Cureus. 2023; 15(7):e42069.

PMID: 37602123 PMC: 10434294. DOI: 10.7759/cureus.42069.


Aortic elasticity changes in thalassemia due to heart and liver iron deposition.

Noori N, Teimouri A Caspian J Intern Med. 2023; 14(3):460-469.

PMID: 37520866 PMC: 10379797.


Quantification of Liver Iron Overload with MRI: Review and Guidelines from the ESGAR and SAR.

Reeder S, Yokoo T, Franca M, Hernando D, Alberich-Bayarri A, Alustiza J Radiology. 2023; 307(1):e221856.

PMID: 36809220 PMC: 10068892. DOI: 10.1148/radiol.221856.


T2-weighted cardiovascular magnetic resonance and echocardiographic arterial elasticity criteria for monitoring cardiac siderosis in patients with beta-thalassemia major.

Zavar R, Hendimarjan M, Behjati M, Yazdani D J Res Med Sci. 2022; 27:44.

PMID: 35968210 PMC: 9374138. DOI: 10.4103/jrms.jrms_705_21.

References
1.
Musallam K, Cappellini M, Wood J, Taher A . Iron overload in non-transfusion-dependent thalassemia: a clinical perspective. Blood Rev. 2012; 26 Suppl 1:S16-9. DOI: 10.1016/S0268-960X(12)70006-1. View

2.
Musallam K, Taher A, Rachmilewitz E . β-thalassemia intermedia: a clinical perspective. Cold Spring Harb Perspect Med. 2012; 2(7):a013482. PMC: 3385943. DOI: 10.1101/cshperspect.a013482. View

3.
Olteanu H, Harrington A, Ramirez S, Kroft S, Hari P . Efficacy and safety of long-term (>7 year) alemtuzumab therapy for refractory T-cell large granular lymphocytic leukaemia. Br J Haematol. 2010; 150(4):480-1. DOI: 10.1111/j.1365-2141.2010.08218.x. View

4.
Musallam K, Motta I, Salvatori M, Fraquelli M, Marcon A, Taher A . Longitudinal changes in serum ferritin levels correlate with measures of hepatic stiffness in transfusion-independent patients with β-thalassemia intermedia. Blood Cells Mol Dis. 2012; 49(3-4):136-9. DOI: 10.1016/j.bcmd.2012.06.001. View

5.
Wood J, Enriquez C, Ghugre N, Tyzka J, Carson S, Nelson M . MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood. 2005; 106(4):1460-5. PMC: 1895207. DOI: 10.1182/blood-2004-10-3982. View